Global News

Profil Institute, LMC Diabetes partnership on cross-border multi-site trials

Wednesday, June 15, 2016

Profil Institute for Clinical Research, a science-driven CRO focused exclusively on metabolic diseases, and LMC Diabetes & Endocrinology, North America’s largest network of investigator sites for diabetes clinical research, have announced a strategic alliance focused on the conduct of cross-border, multi-site clinical research of investigational drugs and devices for diabetes and related metabolic disorders.

[Read More]

ActiGraph launches CentrePoint Data Hub

Wednesday, June 15, 2016

ActiGraph, a provider of wearable activity and sleep measurement solutions for the global pharmaceutical industry and academic research community, has announced the upcoming launch of the CentrePoint Data Hub, a home-based communication gateway that securely transmits data captured by ActiGraph activity monitors and other connected health devices to the CentrePoint cloud software platform via cellular network. The CentrePoint Data Hub is an extension of ActiGraph’s CentrePoint platform, a web-based technology suite used to deploy and manage activity monitor data collection within clinical development and health research environments.

[Read More]

A key to site success is a patient-centered approach

Monday, June 13, 2016

The Pulse on Site Success by Christophe Berthoux

Our industry is inundated with new buzz words and concepts related to innovation, site centricity, patient centricity, patient affairs and patient engagement. It is commonplace to see new job titles and functions created to develop operational processes around these concepts. As clinical research sites, we have focused on understanding the patients we serve face-to-face every day. While the concept of patient centricity may once have been called “patient recruitment” or “patient retention,” these terms include the same elements as those found in the phrase “patient as a participant” emphasized today.

[Read More]

Survey: SCORR to present industry thoughts on Big Data, recruitment, confidentiality

Friday, June 10, 2016

SCORR Marketing, a global health science marketing and communications firm, and Chesapeake IRB, a technology-enabled independent institutional review board (IRB) serving the clinical research industry, will present “Does ‘Big Data’ for Enhanced Recruiting Invade Patient Confidentiality?” and “The Internet of Things and Clinical Research: Privacy, Security and Ethical Aspects” at the Drug Information Association (DIA) Annual Meeting in Philadelphia.

[Read More]

Eli Lilly’s Taltz (ixekizumab) for plaque psoriasis produces positive results

Friday, June 10, 2016

Eli Lilly has announced that the New England Journal of Medicine has published detailed results from three pivotal phase III studies—UNCOVER-1, UNCOVER-2 and UNCOVER-3—that demonstrated the efficacy and safety of Taltz (ixekizumab) through 60 weeks in patients with moderate-to-severe plaque psoriasis. This publication also detailed 12-week efficacy data for patients treated with Taltz in UNCOVER-1.

[Read More]

CRF Health enhances TrialManager for eCOA reporting, data visualization

Wednesday, June 8, 2016

CRF Health, a global provider of eCOA solutions for the life sciences industry, has announced reporting enhancements to TrialManager, its real-time portal for the analysis and management of data collected in clinical trials. The updates bring easy-to-use, role-based visual access to key trial information, further supporting a powerful toolset for the analysis of patient and site data.

[Read More]

Genomic Data Commons launches for data and clinical information sharing

Wednesday, June 8, 2016

The Genomic Data Commons (GDC), a unified data system that promotes sharing of genomic and clinical data between researchers, has launched. An initiative of the National Cancer Institute (NCI), the GDC will be a core component of the National Cancer Moonshot and the President’s Precision Medicine Initiative (PMI), and benefits from $70 million allocated to NCI to lead efforts in cancer genomics as part of PMI for Oncology.

[Read More]